HOW I WOULD MANAGE A 13-YEAR-OLD GIRL WITH NEWLY DIAGNOSED TYPE 1 DIABETES

1 Orchard T. Diabetes: a time for excitement and concern. BMJ 1998; 317:691-2.

2 Rangasami JJ DC Greenwood McSporran B Rising incidence of type 1 diabetes in Scottish children, 1984–93. The Scottish Study Group for the Care of Young Diabetics. Arch Dic Child 1997; 77(3):210-3.

3 Metcalfe MA Baum JD. Incidence of insulin dependent diabetes in children aged under 15 years in the British Isles during 1988. BMJ 1991; 302:443-7.

4 Drash A L Lifshitz , editors. Diabetes mellitus in the child; classification, diagnosis, epidemiology and etiology. New York: Marcel Dekkar; 1996; 555-65.

5 Matyka KA F Beards Appleton M Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia. Arch Dis Child 1998; 78:552-4.

6 Shield JPH Baum JD. Advances in childhood onset diabetes. Arch Dis Child 1998; 78:391-4.

7 Guazzarotti L E Bartolotta Chiarelli F. Maturity-onset diabetes of the young (MODY): a new challenge for pediatric diabetologists. J Pediatr Endocrinol Metab 1999; 12:487-97.

8 Rosenbloom AL JR Joe Young RS Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22:345-54.

9 Morris AM. Diabetes Audit Research Tayside Scotland (DARTS). Personal data available at www.diabeteshealthnet. ac.uk

10 White E AC Wilson Greene SA Body mass index centile charts to assess fatness of British children. Arch Dis Child 1995; 72:38-41.

11 Greene SA. Diabetes in childhood and adolescence. In: Pickup J, Williams G, editors. Textbook of Diabetes. 2nd edition. Oxford: Blackwell Science; 1997; 73·1-7·21.

12de Beaufort CE, Houtzagers CM, Bruining GJ Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989; 6:766-71.

13 Greene S Morris A. The management of brittle diabetes mellitus. Current Paediatrics 1999; 9:247-51.

14The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.

15Greene SA on behalf of the Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycaemic control in young people with Type 1 diabetes in Scotland: A population based study (Diabaud2). Diabetes Care 2001; 24:239-44.

16 Morris AD DIR Boyle McMahon AD For the DARTS/MEMO Collaboration. Adherence to insulin treatment, glycaemic control and ketoacidosis in IDDM. Lancet 1997; 350:1505-10.

17 Steel JM RJ Young Lloyd GG Abnormal eating attitudes in young insulin-dependent diabetics. Br J Psychiatry 1989; 1555:515-21.

18 Mortensen HB K Marinelli Norgaard K and the Danish Study Group of Diabetes in Childhood. A nationwide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with Type 1 diabetes mellitus. Diabet Med 1990; 7:887-97.

19 Rosilio M JB Cotton Wieliczko MC Factors associated with glycaemic control. A cross-sectional nationwide study in 2,579 French children with Type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998; 21:1146-53.

20 Dorchy H. Dorchy’s recipes explaining the ‘Intriguing efficacity of Belgian conventional therapy’ [letter/comment]. Diabetes Care 1994; 17:458-60.

21 Gale EA. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group. Diabet Med 2000; 17:209-14.

22 Pickup JC. Is insulin pump treatment justifiable? In: Gill G, Pickup J and Williams G, editors. Difficult Diabetes. Oxford: Blackwell Science; 2001; 205-23.

23 Greene AC M Tripaldi McKeirnan P Promoting empowerment in young people with Type 1 diabetes. Diabet Med 1999; 16(1):20.

24 Serup P OD Madsen Islet Mandrup-Poulsen T. cell stem transplantation for treating diabetes. BMJ 2001; 322:29-32.

25Hyun Chul Lee, Su-Jin Kim, Kyung-Sup Kim Remission in models of Type 1 diabetes by gene therapy using a singlechain insulin analogue. Nature 2000; 408:483-8.